GALMED PHARMACEUTICALS LTD. Earnings Per Share, Basic and Diluted
GALMED PHARMACEUTICALS LTD. (GLMD) reported Earnings Per Share, Basic and Diluted of $0.33 per share for the 3-month period ending 2021-06-30, per its 6-K filed 2021-08-05.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-08-05
- GALMED PHARMACEUTICALS LTD. earnings per share, basic and diluted for the quarter ending 2021-06-30 was $0.33, a 26.92% increase year-over-year.
- GALMED PHARMACEUTICALS LTD. earnings per share, basic and diluted for the quarter ending 2020-06-30 was $0.26.
- GALMED PHARMACEUTICALS LTD. earnings per share, basic and diluted for the quarter ending 2018-06-30 was $0.17, a 22.73% decline year-over-year.
- GALMED PHARMACEUTICALS LTD. earnings per share, basic and diluted for the quarter ending 2017-06-30 was $0.22.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|
| 2021-06-30 | $0.33 6-K · filed 2021-08-05 | $0.72 6-K · filed 2021-08-05 | |
| 2020-12-31 | -$1.35 derived: net income ÷ weighted average shares · filed 2023-03-29 | ||
| 2020-06-30 | $0.26 6-K · filed 2021-08-05 | $0.55 6-K · filed 2021-08-05 | |
| 2019-12-31 | -$0.97 derived: net income ÷ weighted average shares · filed 2022-05-02 | ||
| 2018-06-30 | $0.17 6-K · filed 2018-08-02 | $0.34 6-K · filed 2018-08-02 | |
| 2017-06-30 | $0.22 6-K · filed 2018-08-02 | $0.48 6-K · filed 2018-08-02 |